1. Gertler R, et al. Dexmedetomidine: a novel sedative-analgesic agent. BUMC Proceedings. 2001; 14:13-21. 2. Virtanen, R et al. Characterization of the selectivity, specificity and potency of medetomidine as an alpha-2 adrenoceptor agonist. EU J of Pharmacol. 1988; 150:9-14. 3. Murell JC, Hellebrekers LJ. Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive properties in the dog. Vet Anaesth Analg. 2005;32:117-127. 4. Ko JC et al. FAQs Sedation analgesia and anesthesia. Making the switch from medetomidine to dexmedetomidine. CCE for Vets, Suppl 2009;31,1A 1-16. 5. Dexdomitor Freedom of Information Summary. NADA 141-267. December 2006. 6. Dexdomitor Freedom of Information Summary. NADA 141-267. Supplemental, May 2010.
IMPORTANT SAFETY INFORMATION Do not use DEXDOMITOR or DEXDOMITOR 0.1 in dogs or cats, and ANTISEDAN in dogs, with cardiovascular disease, respiratory disorders, liver or kidney diseases, or in conditions of shock, severe debilitation, or stress due to extreme heat, cold or fatigue. DEXDOMITOR and DEXDOMITOR 0.1 should not be administered in the presence of preexisting hypotension, hypoxia, or bradycardia. As with all α2-adrenoceptor agonists, the potential for isolated cases of hypersensitivity, including paradoxical response (excitation), exists with DEXDOMITOR and DEXDOMITOR 0.1. The use of DEXDOMITOR and DEXDOMITOR 0.1 as a preanesthetic in dogs and cats significantly reduces the amount of induction and maintenance anesthetic requirements. Careful patient monitoring is necessary to avoid anesthetic overdose. Arrhythmias, bradycardia, apnea, emesis, convulsions, hypersalivation may occur with DEXDOMITOR and DEXDOMITOR 0.1 use. Severe dyspnea and respiratory crackles due to acute or delayed pulmonary edema could develop in cats. DEXDOMITOR and DEXDOMITOR 0.1 have not been evaluated for use in breeding, pregnant, or lactating dogs or cats; in dogs younger than 16 weeks of age or in cats younger than 12 weeks of age; or in geriatric dogs or cats. Occasional vomiting may occur with ANTISEDAN use. Rarely, a brief state of excitement or apprehensiveness may be seen in ANTISEDAN-treated dogs. Other potential side effects of α2-antagonists, such as ANTISEDAN, include hypersalivation, diarrhea, and tremors.